<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2017-10-25" version="175">
<accession>P30304</accession>
<accession>Q8IZH5</accession>
<accession>Q96IL3</accession>
<accession>Q9H2F2</accession>
<name>MPIP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>M-phase inducer phosphatase 1</fullName>
<ecNumber>3.1.3.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Dual specificity phosphatase Cdc25A</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDC25A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="67" first="1181" last="1194">
<title>Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins.</title>
<authorList>
<person name="Galaktionov K.I."/>
<person name="Beach D."/>
</authorList>
<dbReference type="PubMed" id="1836978"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90294-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLY-182</scope>
</reference>
<reference key="2">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Varmeh-Ziaie S."/>
<person name="Manfredi J.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT PHE-88</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Eur. J. Cell Biol." volume="79" first="810" last="815">
<title>Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C.</title>
<authorList>
<person name="Wegener S."/>
<person name="Hampe W."/>
<person name="Herrmann D."/>
<person name="Schaller H.C."/>
</authorList>
<dbReference type="PubMed" id="11139144"/>
<dbReference type="DOI" id="10.1078/0171-9335-00115"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 37-234 (ISOFORM 2)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Nature" volume="410" first="842" last="847">
<title>The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.</title>
<authorList>
<person name="Falck J."/>
<person name="Mailand N."/>
<person name="Syljuaasen R.G."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
</authorList>
<dbReference type="PubMed" id="11298456"/>
<dbReference type="DOI" id="10.1038/35071124"/>
</citation>
<scope>INTERACTION WITH CHEK2</scope>
<scope>PHOSPHORYLATION AT SER-124 BY CHEK2</scope>
<scope>MUTAGENESIS OF SER-124</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="4875" last="4884">
<title>Dual mode of degradation of Cdc25 A phosphatase.</title>
<authorList>
<person name="Donzelli M."/>
<person name="Squatrito M."/>
<person name="Ganoth D."/>
<person name="Hershko A."/>
<person name="Pagano M."/>
<person name="Draetta G.F."/>
</authorList>
<dbReference type="PubMed" id="12234927"/>
<dbReference type="DOI" id="10.1093/emboj/cdf491"/>
</citation>
<scope>UBIQUITINATION BY THE APC/C UBIQUITIN LIGASE COMPLEX</scope>
<scope>DOMAIN KEN BOX MOTIF</scope>
<scope>MUTAGENESIS OF 141-LYS--ASN-143</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14795" last="14800">
<title>Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.</title>
<authorList>
<person name="Zhao H."/>
<person name="Watkins J.L."/>
<person name="Piwnica-Worms H."/>
</authorList>
<dbReference type="PubMed" id="12399544"/>
<dbReference type="DOI" id="10.1073/pnas.182557299"/>
</citation>
<scope>PHOSPHORYLATION AT SER-124</scope>
<scope>MUTAGENESIS OF SER-124</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Cancer Cell" volume="3" first="247" last="258">
<title>Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.</title>
<authorList>
<person name="Soerensen C.S."/>
<person name="Syljuaesen R.G."/>
<person name="Falck J."/>
<person name="Schroeder T."/>
<person name="Roennstrand L."/>
<person name="Khanna K.K."/>
<person name="Zhou B.-B."/>
<person name="Bartek J."/>
<person name="Lukas J."/>
</authorList>
<dbReference type="PubMed" id="12676583"/>
<dbReference type="DOI" id="10.1016/S1535-6108(03)00048-5"/>
</citation>
<scope>PHOSPHORYLATION AT SER-124; SER-178; SER-279 AND SER-293</scope>
<scope>MUTAGENESIS OF SER-124; SER-178; SER-279 AND SER-293</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Genes Dev." volume="17" first="3062" last="3074">
<title>SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.</title>
<authorList>
<person name="Jin J."/>
<person name="Shirogane T."/>
<person name="Xu L."/>
<person name="Nalepa G."/>
<person name="Qin J."/>
<person name="Elledge S.J."/>
<person name="Harper J.W."/>
</authorList>
<dbReference type="PubMed" id="14681206"/>
<dbReference type="DOI" id="10.1101/gad.1157503"/>
</citation>
<scope>INTERACTION WITH BTRC; CUL1 AND FBXW11</scope>
<scope>PHOSPHODEGRON MOTIF</scope>
<scope>PHOSPHORYLATION AT SER-76 AND SER-124</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-76; SER-79; ASP-81 AND SER-82</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="21767" last="21773">
<title>Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chen Z."/>
<person name="Gunasekera A.H."/>
<person name="Sowin T.J."/>
<person name="Rosenberg S.H."/>
<person name="Fesik S."/>
<person name="Zhang H."/>
</authorList>
<dbReference type="PubMed" id="12676925"/>
<dbReference type="DOI" id="10.1074/jbc.M300229200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF CYS-431</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="29824" last="29829">
<title>Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.</title>
<authorList>
<person name="Hassepass I."/>
<person name="Voit R."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="12759351"/>
<dbReference type="DOI" id="10.1074/jbc.M302704200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-76; SER-124 AND SER-178</scope>
<scope>MUTAGENESIS OF SER-76; SER-124 AND SER-178</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="7488" last="7497">
<title>Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.</title>
<authorList>
<person name="Chen M.-S."/>
<person name="Ryan C.E."/>
<person name="Piwnica-Worms H."/>
</authorList>
<dbReference type="PubMed" id="14559997"/>
<dbReference type="DOI" id="10.1128/MCB.23.21.7488-7497.2003"/>
</citation>
<scope>INTERACTION WITH CCNB1 AND YWHAE</scope>
<scope>PHOSPHORYLATION AT SER-178 AND THR-507</scope>
<scope>MUTAGENESIS OF SER-178; CYS-431; THR-507; LYS-514 AND ARG-520</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Int. J. Biochem. Cell Biol." volume="38" first="430" last="443">
<title>The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.</title>
<authorList>
<person name="Bachmann M."/>
<person name="Kosan C."/>
<person name="Xing P.X."/>
<person name="Montenarh M."/>
<person name="Hoffmann I."/>
<person name="Moroy T."/>
</authorList>
<dbReference type="PubMed" id="16356754"/>
<dbReference type="DOI" id="10.1016/j.biocel.2005.10.010"/>
</citation>
<scope>INTERACTION WITH PIM1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Nat. Cell Biol." volume="11" first="1247" last="1253">
<title>NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint.</title>
<authorList>
<person name="Melixetian M."/>
<person name="Klein D.K."/>
<person name="Soerensen C.S."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="19734889"/>
<dbReference type="DOI" id="10.1038/ncb1969"/>
</citation>
<scope>PHOSPHORYLATION AT SER-79; SER-82 AND SER-88</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Cell Cycle" volume="9" first="450" last="455">
<title>NEK11: linking CHK1 and CDC25A in DNA damage checkpoint signaling.</title>
<authorList>
<person name="Soerensen C.S."/>
<person name="Melixetian M."/>
<person name="Klein D.K."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="20090422"/>
<dbReference type="DOI" id="10.4161/cc.9.3.10513"/>
</citation>
<scope>PHOSPHORYLATION AT SER-82 AND SER-88</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="400" last="406">
<title>Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.</title>
<authorList>
<person name="Pereg Y."/>
<person name="Liu B.Y."/>
<person name="O'Rourke K.M."/>
<person name="Sagolla M."/>
<person name="Dey A."/>
<person name="Komuves L."/>
<person name="French D.M."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="20228808"/>
<dbReference type="DOI" id="10.1038/ncb2041"/>
</citation>
<scope>DEUBIQUITINATION BY USP17L2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="Mutat. Res." volume="714" first="1" last="10">
<title>Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors.</title>
<authorList>
<person name="Myer D.L."/>
<person name="Robbins S.B."/>
<person name="Yin M."/>
<person name="Boivin G.P."/>
<person name="Liu Y."/>
<person name="Greis K.D."/>
<person name="Bahassi el M."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="21376736"/>
<dbReference type="DOI" id="10.1016/j.mrfmmm.2011.02.006"/>
</citation>
<scope>PHOSPHORYLATION AT SER-513 AND SER-519 BY PLK3</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-513 AND SER-519</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2012" name="Hum. Mol. Genet." volume="21" first="4615" last="4627">
<title>Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells.</title>
<authorList>
<person name="Giessrigl B."/>
<person name="Krieger S."/>
<person name="Rosner M."/>
<person name="Huttary N."/>
<person name="Saiko P."/>
<person name="Alami M."/>
<person name="Messaoudi S."/>
<person name="Peyrat J.F."/>
<person name="Maciuk A."/>
<person name="Gollinger M."/>
<person name="Kopf S."/>
<person name="Kazlauskas E."/>
<person name="Mazal P."/>
<person name="Szekeres T."/>
<person name="Hengstschlaeger M."/>
<person name="Matulis D."/>
<person name="Jaeger W."/>
<person name="Krupitza G."/>
</authorList>
<dbReference type="PubMed" id="22843495"/>
<dbReference type="DOI" id="10.1093/hmg/dds303"/>
</citation>
<scope>INTERACTION WITH HSP90AB1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107 AND SER-321</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="1998" name="Cell" volume="93" first="617" last="625">
<title>Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A.</title>
<authorList>
<person name="Fauman E.B."/>
<person name="Cogswell J.P."/>
<person name="Lovejoy B."/>
<person name="Rocque W.J."/>
<person name="Holmes W."/>
<person name="Montana V.G."/>
<person name="Piwnica-Worms H."/>
<person name="Rink M.J."/>
<person name="Saper M.A."/>
</authorList>
<dbReference type="PubMed" id="9604936"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81190-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 336-496</scope>
</reference>
<comment type="function">
<text>Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression. Directly dephosphorylates CDK1 and stimulates its kinase activity. Also dephosphorylates CDK2 in complex with cyclin E, in vitro.</text>
</comment>
<comment type="catalytic activity">
<text>Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text>Stimulated by B-type cyclins. Stimulated by PIM1-mediated phosphorylation.</text>
</comment>
<comment type="subunit">
<text evidence="4 10 11 12 18">Interacts with CCNB1/cyclin B1. Interacts with YWHAE/14-3-3 epsilon when phosphorylated. Interacts with CUL1 specifically when CUL1 is neddylated and active. Interacts with BTRC/BTRCP1 and FBXW11/BTRCP2. Interactions with CUL1, BTRC and FBXW11 are enhanced upon DNA damage. Interacts with PIM1. Interacts with CHEK2; mediates CDC25A phosphorylation and degradation in response to infrared-induced DNA damages. Interacts with HSP90AB1; prevents heat shock-mediated CDC25A degradation and contributes to cell cycle progression (PubMed:22843495).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-747671"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-747671"/>
<interactant intactId="EBI-359815">
<id>P31946</id>
<label>YWHAB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-747671"/>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-747671"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P30304-1</id>
<name>1</name>
<name>CDC25A1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P30304-2</id>
<name>2</name>
<name>CDC25A2</name>
<sequence type="described" ref="VSP_000860"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="5">The phosphodegron motif mediates interaction with specific F-box proteins when phosphorylated. Putative phosphorylation sites at Ser-79 and Ser-82 appear to be essential for this interaction.</text>
</comment>
<comment type="PTM">
<text evidence="4 6 7 8 9 10 11 14 15 16 17">Phosphorylated by CHEK1 on Ser-76, Ser-124, Ser-178, Ser-279, Ser-293 and Thr-507 during checkpoint mediated cell cycle arrest. Also phosphorylated by CHEK2 on Ser-124, Ser-279, and Ser-293 during checkpoint mediated cell cycle arrest. Phosphorylation on Ser-178 and Thr-507 creates binding sites for YWHAE/14-3-3 epsilon which inhibits CDC25A. Phosphorylation on Ser-76, Ser-124, Ser-178, Ser-279 and Ser-293 may also promote ubiquitin-dependent proteolysis of CDC25A by the SCF complex. Phosphorylation of CDC25A at Ser-76 by CHEK1 primes it for subsequent phosphorylation at Ser-79, Ser-82 and Ser-88 by NEK11. Phosphorylation by NEK11 is required for BTRC-mediated polyubiquitination and degradation. Phosphorylation by PIM1 leads to an increase in phosphatase activity. Phosphorylated by PLK3 following DNA damage, leading to promote its ubiquitination and degradation.</text>
</comment>
<comment type="PTM">
<text evidence="16">Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase complex that contains FZR1/CDH1 during G1 phase leading to its degradation by the proteasome. Ubiquitinated by a SCF complex containing BTRC and FBXW11 during S phase leading to its degradation by the proteasome. Deubiquitination by USP17L2/DUB3 leads to its stabilization.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the MPI phosphatase family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CDC25AID40004ch3p21.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdc25a/"/>
</comment>
<dbReference type="EC" id="3.1.3.48"/>
<dbReference type="EMBL" id="M81933">
<property type="protein sequence ID" value="AAA58415.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY137580">
<property type="protein sequence ID" value="AAN11305.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF527417">
<property type="protein sequence ID" value="AAM77917.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007401">
<property type="protein sequence ID" value="AAH07401.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018642">
<property type="protein sequence ID" value="AAH18642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277722">
<property type="protein sequence ID" value="AAG41884.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2760.1">
<molecule id="P30304-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2761.1">
<molecule id="P30304-2"/>
</dbReference>
<dbReference type="PIR" id="A41648">
<property type="entry name" value="A41648"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001780.2">
<molecule id="P30304-1"/>
<property type="nucleotide sequence ID" value="NM_001789.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_963861.1">
<molecule id="P30304-2"/>
<property type="nucleotide sequence ID" value="NM_201567.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011532618.1">
<molecule id="P30304-1"/>
<property type="nucleotide sequence ID" value="XM_011534316.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.437705"/>
<dbReference type="PDB" id="1C25">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=337-496"/>
</dbReference>
<dbReference type="PDBsum" id="1C25"/>
<dbReference type="ProteinModelPortal" id="P30304"/>
<dbReference type="SMR" id="P30304"/>
<dbReference type="BioGrid" id="107428">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="DIP" id="DIP-166N"/>
<dbReference type="ELM" id="P30304"/>
<dbReference type="IntAct" id="P30304">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="MINT" id="MINT-124723"/>
<dbReference type="STRING" id="9606.ENSP00000303706"/>
<dbReference type="BindingDB" id="P30304"/>
<dbReference type="ChEMBL" id="CHEMBL3775"/>
<dbReference type="DEPOD" id="P30304"/>
<dbReference type="iPTMnet" id="P30304"/>
<dbReference type="PhosphoSitePlus" id="P30304"/>
<dbReference type="BioMuta" id="CDC25A"/>
<dbReference type="DMDM" id="50403734"/>
<dbReference type="EPD" id="P30304"/>
<dbReference type="MaxQB" id="P30304"/>
<dbReference type="PaxDb" id="P30304"/>
<dbReference type="PeptideAtlas" id="P30304"/>
<dbReference type="PRIDE" id="P30304"/>
<dbReference type="DNASU" id="993"/>
<dbReference type="Ensembl" id="ENST00000302506">
<molecule id="P30304-1"/>
<property type="protein sequence ID" value="ENSP00000303706"/>
<property type="gene ID" value="ENSG00000164045"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000351231">
<molecule id="P30304-2"/>
<property type="protein sequence ID" value="ENSP00000343166"/>
<property type="gene ID" value="ENSG00000164045"/>
</dbReference>
<dbReference type="GeneID" id="993"/>
<dbReference type="KEGG" id="hsa:993"/>
<dbReference type="UCSC" id="uc003csh.2">
<molecule id="P30304-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="993"/>
<dbReference type="DisGeNET" id="993"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000164045.11"/>
<dbReference type="GeneCards" id="CDC25A"/>
<dbReference type="HGNC" id="HGNC:1725">
<property type="gene designation" value="CDC25A"/>
</dbReference>
<dbReference type="HPA" id="HPA005855"/>
<dbReference type="MIM" id="116947">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P30304"/>
<dbReference type="OpenTargets" id="ENSG00000164045"/>
<dbReference type="PharmGKB" id="PA26259"/>
<dbReference type="eggNOG" id="KOG3772">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5105">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000018747"/>
<dbReference type="HOGENOM" id="HOG000082672"/>
<dbReference type="HOVERGEN" id="HBG052501"/>
<dbReference type="InParanoid" id="P30304"/>
<dbReference type="KO" id="K06645"/>
<dbReference type="OMA" id="NLTVTMD"/>
<dbReference type="OrthoDB" id="EOG091G0H0D"/>
<dbReference type="PhylomeDB" id="P30304"/>
<dbReference type="TreeFam" id="TF101056"/>
<dbReference type="BRENDA" id="3.1.3.48">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1362277">
<property type="pathway name" value="Transcription of E2F targets under negative control by DREAM complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-156711">
<property type="pathway name" value="Polo-like kinase mediated events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176187">
<property type="pathway name" value="Activation of ATR in response to replication stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69202">
<property type="pathway name" value="Cyclin E associated events during G1/S transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69273">
<property type="pathway name" value="Cyclin A/B1/B2 associated events during G2/M transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69601">
<property type="pathway name" value="Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69656">
<property type="pathway name" value="Cyclin A:Cdk2-associated events at S phase entry"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8862803">
<property type="pathway name" value="Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"/>
</dbReference>
<dbReference type="SIGNOR" id="P30304"/>
<dbReference type="ChiTaRS" id="CDC25A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P30304"/>
<dbReference type="GeneWiki" id="CDC25A"/>
<dbReference type="GenomeRNAi" id="993"/>
<dbReference type="PRO" id="PR:P30304"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000164045"/>
<dbReference type="CleanEx" id="HS_CDC25A"/>
<dbReference type="ExpressionAtlas" id="P30304">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P30304">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004721">
<property type="term" value="F:phosphoprotein phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004725">
<property type="term" value="F:protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1902751">
<property type="term" value="P:positive regulation of cell cycle G2/M phase transition"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000079">
<property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009314">
<property type="term" value="P:response to radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd01530">
<property type="entry name" value="Cdc25"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.250.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000751">
<property type="entry name" value="MPI_Phosphatase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001763">
<property type="entry name" value="Rhodanese-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036873">
<property type="entry name" value="Rhodanese-like_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF06617">
<property type="entry name" value="M-inducer_phosp"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00581">
<property type="entry name" value="Rhodanese"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00716">
<property type="entry name" value="MPIPHPHTASE"/>
</dbReference>
<dbReference type="SMART" id="SM00450">
<property type="entry name" value="RHOD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52821">
<property type="entry name" value="SSF52821"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50206">
<property type="entry name" value="RHODANESE_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="M-phase inducer phosphatase 1" id="PRO_0000198641">
<location>
<begin position="1"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="Rhodanese" evidence="3">
<location>
<begin position="376"/>
<end position="482"/>
</location>
</feature>
<feature type="short sequence motif" description="Phosphodegron">
<location>
<begin position="74"/>
<end position="84"/>
</location>
</feature>
<feature type="short sequence motif" description="KEN box">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="active site">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK1" evidence="9 11">
<location>
<position position="76"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by NEK11" evidence="14">
<location>
<position position="79"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by NEK11" evidence="14 15">
<location>
<position position="82"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by NEK11" evidence="14 15">
<location>
<position position="88"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK1 and CHEK2" evidence="4 6 7 9 11">
<location>
<position position="124"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK1" evidence="7 9 10">
<location>
<position position="178"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK1 and CHEK2" evidence="7">
<location>
<position position="279"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK1 and CHEK2" evidence="7">
<location>
<position position="293"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="321"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CHEK1" evidence="10">
<location>
<position position="507"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="17">
<location>
<position position="513"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="17">
<location>
<position position="519"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_000860" evidence="20 21">
<location>
<begin position="144"/>
<end position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3731499." id="VAR_020932" evidence="19">
<original>S</original>
<variation>F</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6771386." id="VAR_023532" evidence="13">
<original>R</original>
<variation>G</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6771386." id="VAR_023533">
<original>R</original>
<variation>W</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination and impairs CHEK1-dependent degradation following checkpoint activation." evidence="9 11">
<original>S</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interactions with BTRC and FBXW11 and prevents ubiquitination." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interactions with BTRC and FBXW11 and prevents ubiquitination." evidence="11">
<original>D</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interactions with BTRC and FBXW11 and prevents ubiquitination." evidence="11">
<original>S</original>
<variation>A</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates phosphorylation by CHEK2 and infrared-induced degradation. Increases basal stability and impairs CHEK1-dependent degradation following checkpoint activation; when associated with A-178; A-279 and A-293." evidence="4 6 7 9">
<original>S</original>
<variation>A</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents ubiquitination and subsequent degradation by the APC/C ubiquitin ligase complex." evidence="5">
<original>KEN</original>
<variation>AAA</variation>
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases basal stability and impairs CHEK1-dependent degradation following checkpoint activation; when associated with A-124; A-279 and A-293. Abrogates 14-3-3 protein binding." evidence="7 9 10">
<original>S</original>
<variation>A</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases basal stability and impairs CHEK1-dependent degradation following checkpoint activation; when associated with A-124; A-178 and A-293." evidence="7">
<original>S</original>
<variation>A</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases basal stability and impairs CHEK1-dependent degradation following checkpoint activation; when associated with A-124; A-178 and A-279." evidence="7">
<original>S</original>
<variation>A</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphatase activity." evidence="8 10">
<original>C</original>
<variation>S</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates 14-3-3 protein binding; increases binding to cyclin B1." evidence="10">
<original>T</original>
<variation>A</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased stability following IR treatment." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, leading to promote degradation following IR treatment." evidence="17">
<original>S</original>
<variation>D</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to CCNB1; when associated with L-520." evidence="10">
<original>K</original>
<variation>L</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased stability following IR treatment." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="519"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, leading to promote degradation following IR treatment." evidence="17">
<original>S</original>
<variation>D</variation>
<location>
<position position="519"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates binding to CCNB1; when associated with L-514." evidence="10">
<original>R</original>
<variation>L</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58415." ref="1" evidence="22">
<original>EPPHR</original>
<variation>SPAP</variation>
<location>
<begin position="6"/>
<end position="10"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58415." ref="1" evidence="22">
<original>PA</original>
<variation>QL</variation>
<location>
<begin position="180"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="341"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="362"/>
<end position="369"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="370"/>
<end position="376"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="377"/>
<end position="384"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="388"/>
<end position="392"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="405"/>
<end position="411"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="412"/>
<end position="414"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="423"/>
<end position="430"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="432"/>
<end position="436"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="437"/>
<end position="451"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="463"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="469"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="478"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="481"/>
<end position="484"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1C25"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00173"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11298456"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12234927"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12399544"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676583"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676925"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12759351"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14559997"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14681206"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16356754"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1836978"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19734889"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20090422"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20228808"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21376736"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22843495"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11139144"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="524" mass="59087" checksum="B2F6B792D4E6122B" modified="2004-07-19" version="2">
MELGPEPPHRRRLLFACSPPPASQPVVKALFGASAAGGLSPVTNLTVTMDQLQGLGSDYE
QPLEVKNNSNLQRMGSSESTDSGFCLDSPGPLDSKENLENPMRRIHSLPQKLLGCSPALK
RSHSDSLDHDIFQLIDPDENKENEAFEFKKPVRPVSRGCLHSHGLQEGKDLFTQRQNSAP
ARMLSSNERDSSEPGNFIPLFTPQSPVTATLSDEDDGFVDLLDGENLKNEEETPSCMASL
WTAPLVMRTTNLDNRCKLFDSPSLCSSSTRSVLKRPERSQEESPPGSTKRRKSMSGASPK
ESTNPEKAHETLHQSLSLASSPKGTIENILDNDPRDLIGDFSKGYLFHTVAGKHQDLKYI
SPEIMASVLNGKFANLIKEFVIIDCRYPYEYEGGHIKGAVNLHMEEEVEDFLLKKPIVPT
DGKRVIVVFHCEFSSERGPRMCRYVRERDRLGNEYPKLHYPELYVLKGGYKEFFMKCQSY
CEPPSYRPMHHEDFKEDLKKFRTKSRTWAGEKSKREMYSRLKKL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>